MedTrace Logo

Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data

NCT01145898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2014-01-22

Study results available
· View outcomes & findings →

Summary

To analyze Cosopt® in terms of its effects on ocular perfusion pressure and comprehensive ocular blood flow and in relation to visual field progression and optic nerve structural changes in an ongoing 3 year prospective study involving 120 patients with open angle glaucoma.

Conditions

Interventions

DRUG

(Cosopt®, prostaglandin)

We did NOT provide any intervention, we observed groups of patients already on these drugs as observers only.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Alon Harris, PhD · Indiana University School of Medicine

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-01-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145898 on ClinicalTrials.gov